Description
ARA-290 – Advanced Research Peptide for Inflammation and Tissue Repair
ARA-290 is a synthetic peptide derived from erythropoietin (EPO), specifically engineered to selectively activate the innate repair receptor (IRR) without stimulating red blood cell production. This unique mechanism makes it a promising research compound for exploring potential benefits in reducing inflammation, alleviating neuropathic pain, and promoting tissue regeneration.
Unlike native EPO, which carries risks of excessive erythropoiesis, ARA-290 has been designed to provide the protective and reparative properties of EPO while avoiding hematopoietic side effects. Studies suggest it may have applications in conditions involving nerve damage, autoimmune inflammation, diabetes-related complications, and ischemic injury.
Key Features:
-
Non-erythropoietic EPO-derived peptide
-
Targets the innate repair receptor (IRR)
-
Investigated for neuropathic pain relief
-
Studied for anti-inflammatory properties
-
Potential role in tissue and organ protection
Research Applications:
-
Neuropathic pain models
-
Autoimmune and inflammatory pathways
-
Tissue repair and regeneration
-
Metabolic and vascular complications
